ELIXERA, INC.
Menlo Park, CA · Biotech · Private
Monoclonal antibody therapeutic targeting cortisol for Cushing's disease treatment
- Grants
- $2.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A First-in-Class Human Antibody Therapeutic for Treatment of Cushing's Disease | $224,624 | |
| Federal grant | Department of Health and Human Services · Phase I · A First-in-Class Antibody Therapeutic for Treatment of Acromegaly | $284,100 | |
| Federal grant | Department of Health and Human Services · Phase II · A First-in-Class Therapeutic Antibody for Treatment of Acromegaly | $1,035,589 | |
| Federal grant | Department of Health and Human Services · Phase II · A First-in-Class Therapeutic Antibody for Treatment of Acromegaly | $1,059,814 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1284 | XLOCK BIOSCIENCES, LLC | — | — |
| 1285 | GENETIC INTELLIGENCE | — | — |
| 1286 | BINARY GENOMICS, INC. | — | — |
| 1287 | ELIXERA, INC. | — | — |
| 1288 | Distributed Bio, Inc. | — | — |
| 1289 | PIPA LLC | — | — |
| 1290 | Aurora Oncology, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.